The pharmaceutical industry is seeing a major shift in diabetes treatment with the introduction of GLP-1 transdermal devices. These groundbreaking methods offer a likely simple option to injections for individuals living with type 2 diabetes. By avoiding the necessity for frequent needles, GLP-1 skin devices promise to improve user compliance an… Read More